Ligand Pharmaceuticals Inc (LGND) insider trading
Every open-market stock purchase and sale by Ligand Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $17M over the last 12 months (23 sales). No open-market buys.
- Last insider buy: Todd C Davis (CEO), $584K, 17 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $17M (23 sales). Last close $237.00 on Jun 4, 2026.
Recent LGND insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | Stephen L Sabba (Director) | Sold | $545K |
| Jun 16, 2026 | Stephen L Sabba (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Jason Haas (Director) | Sold | $886K |
| Jun 12, 2026 | Jason Haas (Director) | Sold | $765K |
| Jun 12, 2026 | Jason Haas (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Jason Haas (Director) | Bought (not open market) | — |
| Jun 11, 2026 | Jason Aryeh (Director) | Sold | $1.1M |
| Jun 10, 2026 | John L Lamattina (Director) | Sold | $857K |
| Jun 10, 2026 | John L Lamattina (Director) | Sold | $174K |
| Jun 10, 2026 | Jason Aryeh (Director) | Sold | $125K |
| Jun 10, 2026 | John L Lamattina (Director) | Sold | $63.5K |
| Jun 10, 2026 | John L Lamattina (Director) | Sold | $57.6K |
| Jun 5, 2026 | Martine Zimmermann (Director) | Sold (not open market) | $43.1K |
| Jun 5, 2026 | Jason Aryeh (Director) | Bought (not open market) | — |
| Jun 5, 2026 | John L Lamattina (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Jason Haas (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Stephen L Sabba (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Nancy Ryan Gray (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Martine Zimmermann (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Jason Aryeh (Director) | Bought (not open market) | — |
| Jun 5, 2026 | John W Kozarich (Director) | Bought (not open market) | — |
| Jun 5, 2026 | John L Lamattina (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Jason Haas (Director) | Bought (not open market) | — |
| Jun 5, 2026 | John W Kozarich (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Martine Zimmermann (Director) | Bought (not open market) | — |
Who's trading LGND
- Stephen L Sabba, Director: sold $1.2M (3 sales), last Jun 16, 2026
- Jason Haas, Director: sold $1.7M (2 sales), last Jun 12, 2026
- Jason Aryeh, Director: sold $1.3M (2 sales), last Jun 11, 2026
- John L Lamattina, Director: sold $2.4M (7 sales), last Jun 10, 2026
- Martine Zimmermann, Director: other filings, last Jun 5, 2026
- Nancy Ryan Gray, Director: sold $1.4M (2 sales), last Jun 5, 2026
- John W Kozarich, Director: sold $1.1M (37 sales), last Jun 5, 2026
- Andrew Reardon, C-suite exec: sold $4.3M (30 sales), last Jun 1, 2026
- Octavio Espinoza, CFO: sold $3.8M (13 sales), last May 27, 2026
- Todd C Davis, CEO: other filings, last Mar 2, 2026
Get free alerts when an insider at Ligand Pharmaceuticals Inc files a new trade →